(Q57413975)

English

Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial

article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial (English)

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mihai Gheorghiade

11

object named as

Mihai Gheorghiade

0 references

Wendy Gattis Stough

7

object named as

Wendy Gattis Stough

0 references

Donald Lloyd-Jones

4

object named as

Donald Lloyd‐Jones

0 references

Kirkwood F Adams

5

object named as

Kirkwood F. Adams

0 references

James E Udelson

3

object named as

James E. Udelson

0 references

Christopher M. Oconnor

6

object named as

Christopher M. Oconnor

0 references

1

object named as

Joseph Rossi

0 references

10

object named as

Cesare Orlandi

0 references

author name string

Melike Bayram

2

0 references

John Ouyang

8

0 references

David D. Shin

9

0 references

publication date

January 2007

0 references

Acute Cardiac Care

0 references

9

0 references

2

0 references

82-86

0 references

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Acute heart failure syndromes: current state and framework for future research

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Risk stratification after hospitalization for decompensated heart failure

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Hyponatremia in congestive heart failure

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Diuretic complications

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

The Neurohumoral Axis in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Relation of loop diuretic dose to mortality in advanced heart failure

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

The Seattle Heart Failure Model: prediction of survival in heart failure

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Vasopressin V2 Receptor Blockade With Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

1 reference

https://api.crossref.org/works/10.1080%2F17482940701210179

21 January 2018

Identifiers

10.1080/17482940701210179

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57413975&oldid=1820025274"